A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone

Summary

The purpose of this study is to evaluate the effects of an organic cation transporter inhibitor, trimethoprim, on the pharmacokinetics of orally administered ER OROS paliperidone and to assess the safety and tolerability of the treatments in healthy male volunteers.

Timeline

Start

2004-10

Primary completion

—

Completion

2004-11

Drugs

Indications